Host: |
Rabbit |
Applications: |
WB/IF |
Reactivity: |
Human/Mouse/Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit monoclonal antibody anti-KIFAP3 (675-792) is suitable for use in Western Blot and Immunofluorescence research applications. |
Clonality: |
Monoclonal |
Clone ID: |
S7MR |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.02% Sodium Azide, 0.05% BSA, 50% Glycerol, pH7.3. |
Purification: |
Affinity purification |
Dilution Range: |
WB 1:500-1:1000IF/ICC 1:50-1:200 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
KIFAP3 |
Gene ID: |
22920 |
Uniprot ID: |
KIFA3_HUMAN |
Immunogen Region: |
675-792 |
Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 675-792 of human KIFAP3 (Q92845). |
Immunogen Sequence: |
KFRWHNSQWLEMVESRQMDE SEQYLYGDDRIEPYIHEGDI LERPDLFYNSDGLIASEGAI SPDFFNDYHLQNGDVVGQHS FPGSLGMDGFGQPVGILGRP ATAYGFRPDEPYYYGYGS |
Post Translational Modifications | Phosphorylated on tyrosine residues by SRC in vitro.this reduces the binding affinity of the protein for RAP1GDS1. |
Function | Involved in tethering the chromosomes to the spindle pole and in chromosome movement. Binds to the tail domain of the KIF3A/KIF3B heterodimer to form a heterotrimeric KIF3 complex and may regulate the membrane binding of this complex. |
Protein Name | Kinesin-Associated Protein 3Kap-3Kap3Smg Gds-Associated Protein |
Database Links | Reactome: R-HSA-1445148Reactome: R-HSA-2132295Reactome: R-HSA-5620924Reactome: R-HSA-6811434Reactome: R-HSA-983189 |
Alternative Antibody Names | Anti-Kinesin-Associated Protein 3 antibodyAnti-Kap-3 antibodyAnti-Kap3 antibodyAnti-Smg Gds-Associated Protein antibodyAnti-KIFAP3 antibodyAnti-KIF3AP antibodyAnti-SMAP antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance